75
Participants
Start Date
October 9, 2023
Primary Completion Date
March 11, 2024
Study Completion Date
March 11, 2024
bupivacaine and dexmedetomidine.
patient will receive Ultrasound -guided Supraclavicular brachial plexus block with 20 ml bupivacaine 0.5% + 1 μg/kg dexmedetomidine.
bupivacaine only
patient will receive Ultrasound -guided Supraclavicular brachial plexus block with 20 ml bupivacaine 0.5% without additives
bupivacaine
patient will receive Ultrasound -guided Supraclavicular brachial plexus block with 30 ml bupivacaine 0.5% without additives as a control group.
Kafrelsheikh University, Kafr ash Shaykh
Kafrelsheikh University
OTHER